Yahoo Malaysia Web Search

Sign In

Search results

  1. www.forbes.com › profile › timothy-springerTimothy Springer - Forbes

    3 hari yang lalu · Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School. He was a founding investor in publicly...

  2. Images

    • How Harvard Medical School Professor Timothy Springer Made Hundreds Of ...
    • QnAs with Richard O. Hynes, Erkki Ruoslahti, and Timothy A. Springer ...
    • New Research Institute Promises to Transform Protein Science and Drug ...
    • Timothy A. Springer, PhD | Springer Lab
    • Timothy A. Springer - Gairdner Foundation Award Winner

    View all

  3. www.forbes.com › sites › giacomotogniniBillionaire Harvard Professor’s Fortune Jumps Nearly $200 Million...

    8 Jul 2024 · Harvard professor Timothy Springer first made headlines in 2020 when a biotech company he had invested in—Moderna—suddenly became a household name thanks to its Covid-19 vaccines, sparking a...

  4. qz.com › eli-lilly-harvard-professor-1851582748Eli Lilly's purchase of Morphic enriches Harvard professor...

    9 Jul 2024 · Timothy Springer, a professor of biological chemistry and molecular pharmacology at Harvard University, became $200 million richer on Monday after Eli Lilly announced it was acquiring a biotech...

  5. markets.businessinsider.com › news › stocksFavorable Outlook for Eli Lilly’s Acquisition of Morphic Holding...

    9 Jul 2024 · The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA. Read More on MORF: M&A News: Eli Lilly Snaps Up Morphic in $3.2B Deal. Lilly to Acquire Morphic...

  6. markets.businessinsider.com › news › stocksMorphic Holding Buy Rating: High Acquisition Premium and...

    6 hari yang lalu · The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA. Read More on MORF: Morphic downgraded to Hold from Buy at Canaccord

  7. Videos

    View all

  8. ir.cartesiantherapeutics.com › news-releases › news-release-detailsCartesian Therapeutics Announces $130 Million Private Placement...

    2 Jul 2024 · The PIPE financing included participation from both new and existing investors, including HBM Healthcare Investments (Cayman) Ltd., Invus, Schooner Capital, Surveyor Capital (a Citadel company), Timothy A. Springer, Ph.D., a leading mutual fund manager, and other institutional investors.

  9. www.packgene.com › frontier › 240703Cartesian Therapeutics Secures $130M in PIPE Financing for...

    3 Jul 2024 · The PIPE financing saw robust participation from both new and existing investors, including notable names such as HBM Healthcare Investments (Cayman) Ltd., Invus, Schooner Capital, Surveyor Capital (a Citadel company), and renowned mutual fund manager Timothy A. Springer, Ph.D.